Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2019

Mar 12, 2019

35221_dirs_2019-03-12_0dc6da2c-4a48-4b50-a7c1-91a0fecd1f7e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2019-03-07

Reporting Person: Battleman David S. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-03-07 Employee Stock Option (Right to Buy) $1.00 A 200000 Acquired 2029-03-07 Common Stock (200000) Direct

Footnotes

F1: The option vests in 12 equal quarterly installments commencing on March 31, 2019.